PICC

AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture

Retrieved on: 
Thursday, April 4, 2024
Health, Oncology, Cardiology, Medical Devices, Radio, MED, Dialysis, Pulmonary embolism, Growth, Patient, News, Nanoknife, Cancer, Public expenditure, Table, APEX, Quality of life, PICC, Radiofrequency ablation, IP, GAAP, Patent, Starburst, FDA, Medical laboratory scientist, Pharmaceutical industry

Net sales for the third quarter of fiscal year 2024 were $66.0 million, an increase of 8.0% compared to the prior-year quarter.

Key Points: 
  • Net sales for the third quarter of fiscal year 2024 were $66.0 million, an increase of 8.0% compared to the prior-year quarter.
  • U.S. net sales in the third quarter of fiscal 2024 were $55.8 million, an increase of 5.9% from sales of $52.7 million a year ago.
  • GAAP reported gross margin was 47.7%, a decrease of 250 basis points compared to the third quarter of fiscal 2023.
  • On a pro forma basis, gross margin for the third quarter of fiscal 2024 was 51.1%, a decline of 290 basis points from the third quarter of fiscal 2023.

ICP DAS-BMP Secures Pivotal TPU Deals with Medical Materials Leaders in U.S. and Japan, Boosts Product Reliability

Retrieved on: 
Tuesday, March 19, 2024
DAS, Hardness, Plasticizer, ARC, ESG, PICC, Barium sulfate, ICP, ALP, ALC, Research, Volatile organic compound, ARP, Plastic, TPU, Medical device

ICP DAS-BMP, Asia's first medical-grade TPU supplier, produces three main series of products: Alithane™ (ALP series), Durathane™ (ALC series), and Arothane™ (ARP series).

Key Points: 
  • ICP DAS-BMP, Asia's first medical-grade TPU supplier, produces three main series of products: Alithane™ (ALP series), Durathane™ (ALC series), and Arothane™ (ARP series).
  • All the TPU series are available in different hardness levels, colors, and concentrations of radiopaque fillers (Tungsten/Barium Sulfate).
  • These materials are widely utilized in manufacturing cardiovascular, urological, and gastrointestinal devices, as well as medical and electromedical consumables.
  • ICP DAS-BMP aims to offer safer, stable, and eco-friendly medical-grade TPU, collaborating with global medical device manufacturers to create long-term benefits and value.

ICP DAS-BMP Secures Pivotal TPU Deals with Medical Materials Leaders in U.S. and Japan, Boosts Product Reliability

Retrieved on: 
Tuesday, March 19, 2024
DAS, Hardness, Plasticizer, ARC, ESG, PICC, Barium sulfate, ICP, ALP, ALC, Research, Volatile organic compound, ARP, Plastic, TPU, Medical device

ICP DAS-BMP, Asia's first medical-grade TPU supplier, produces three main series of products: Alithane™ (ALP series), Durathane™ (ALC series), and Arothane™ (ARP series).

Key Points: 
  • ICP DAS-BMP, Asia's first medical-grade TPU supplier, produces three main series of products: Alithane™ (ALP series), Durathane™ (ALC series), and Arothane™ (ARP series).
  • All the TPU series are available in different hardness levels, colors, and concentrations of radiopaque fillers (Tungsten/Barium Sulfate).
  • These materials are widely utilized in manufacturing cardiovascular, urological, and gastrointestinal devices, as well as medical and electromedical consumables.
  • ICP DAS-BMP aims to offer safer, stable, and eco-friendly medical-grade TPU, collaborating with global medical device manufacturers to create long-term benefits and value.

Access Vascular Supports Updated Standards of Care Emphasizing New Materials to Reduce Catheter Complications

Retrieved on: 
Wednesday, February 28, 2024
Nursing, Medical Supplies, Health, Medical Devices, Hospitals, Other Health, Managed Care, Bloodstream infections, Thrombosis, Occlusion, INS, PICC, Phlebitis, Catheter, AVI, Patient, HBM, Risk

Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications with its novel hydrophilic biomaterial platform, today announced that the Infusion Nurses Society (INS) has updated its standard of care to include innovative catheter materials, to reduce the risk of vascular access complications.

Key Points: 
  • Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications with its novel hydrophilic biomaterial platform, today announced that the Infusion Nurses Society (INS) has updated its standard of care to include innovative catheter materials, to reduce the risk of vascular access complications.
  • The new INS guidelines cite improvements in catheter materials as having the potential to reduce complications such as phlebitis, occlusion, and thrombosis.1 The guidelines also advise healthcare providers to consider using devices made of novel materials in populations with high rates of occlusion or thrombosis.
  • Studies have shown that peripherally inserted central catheters (PICC) and midline catheters made using AVI’s MIMIX™ hydrophilic biomaterial (HBM) offer lower rates of failure,2 occlusion,3 bacterial adhesion and thrombus accumulation,4 compared with catheters made from conventional polyurethane materials.
  • “Rates of bloodstream infections have soared, at great cost to the U.S. healthcare system and, most importantly, leading to a myriad of patient complications,” said James Biggins, Founder and CEO of Access Vascular.

Global IV Catheters Market Insights Report 2023-2029: Peripheral Inserted Central Catheters (PICCs) Leading the Charge - ResearchAndMarkets.com

Retrieved on: 
Friday, February 23, 2024
Medical Devices, Health, Diabetes, Incidence, Alzheimer's disease, Infection, ICU, USD, European, Ageing, Growth, Cancer, Conditional sentence, Stroke, Hospital, Government, Short, ICU Medical, Prevalence, Safety, Malaria, Nutrient, PICC, Life expectancy, Injury, Patient, Dementia, Tuberculosis, CVC, Developed country, COPD, Medical device

The global IV catheters market was valued at USD 4.93 billion in 2023 and is expected to reach a value of $6.64 billion by 2029, growing at a CAGR of 5.04%

Key Points: 
  • The global IV catheters market was valued at USD 4.93 billion in 2023 and is expected to reach a value of $6.64 billion by 2029, growing at a CAGR of 5.04%
    The global IV catheters market report contains exclusive data on 33 vendors.
  • BD, B Braun, Terumo, Teleflex, ICU Medical, and Nipro Medical are some leading players currently dominating the global IV catheters market.
  • The continuous growth in individuals with chronic conditions and the rapidly expanding elderly population are the primary factors fueling the global demand for peripheral IV catheters.
  • The peripheral inserted central catheters (PICCs) product segment accounted for the highest market share of over 45% of the global CIVCs market.

AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million

Retrieved on: 
Thursday, February 15, 2024
Oncology, Medical Supplies, Health, Surgery, Cardiology, Biotechnology, Acquisition, Marketing, Sale, Cadwalader, Medical laboratory scientist, Radiofrequency ablation, Dialysis, PICC, Nanoknife, Cadwalader, Wickersham & Taft, UBS, Cancer, Security (finance)

The transaction consists of AngioDynamics’ PICC, Midline and tip location products.

Key Points: 
  • The transaction consists of AngioDynamics’ PICC, Midline and tip location products.
  • This combined portfolio of products contributed approximately $43.5 million in annual sales during AngioDynamics’ fiscal year 2023.
  • These products contributed approximately $5.5 million in annual sales during AngioDynamics’ fiscal year 2023.
  • The divestiture of the PICC and Midline businesses, together with the discontinuance of the radiofrequency ablation and Syntrax businesses, will reduce full-year fiscal 2024 revenue by approximately $50 million.

Teleflex Awarded Peripheral Access Agreement with Premier, Inc.

Retrieved on: 
Tuesday, December 5, 2023
Peripheral, PICC, TFX, Premier, VPS, CLABSI, Hospital, Catheter, Navigation, Patient, Teleflex, Fungal infection, Medical imaging

WAYNE, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded the Peripheral Access purchasing agreement with Premier, Inc.

Key Points: 
  • WAYNE, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded the Peripheral Access purchasing agreement with Premier, Inc.
  • Effective December 1st, 2023, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Teleflex’s Peripheral Access products.
  • Premier has awarded Teleflex a national multi-source agreement for Peripherally Inserted Central Catheters (PICCs), PICC navigation equipment, and Midlines.
  • “Teleflex strives to deliver vascular access products that are designed to benefit both clinicians and patients, while helping to protect against vascular access related complications1-7,” said Lisa Kudlacz, President and General Manager, Teleflex Vascular.

Global Vascular Access Devices (MedSuite) Market Size, Share & Trends Analysis 2024-2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, November 17, 2023
Medical Supplies, Medical Devices, Health, Surgery, Cardiology, Biotechnology, PICC, Teleflex, Central venous catheter, Acquisition, Research, BD (company), Risk, Catheter, Peripherally inserted central catheter, CVC, Growth, Bard (company), Medical imaging, Medical device

The "Global Vascular Access Devices Market Size, Share & Trends Analysis 2024-2030 - MedSuite" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Vascular Access Devices Market Size, Share & Trends Analysis 2024-2030 - MedSuite" report has been added to ResearchAndMarkets.com's offering.
  • While this MedSuite report provides a comprehensive overview of the Global Vascular Access Devices market, you also have the option to access each market segment individually as stand-alone MedCore reports.
  • The global vascular access device market is on the brink of substantial expansion, and long-term devices like implantable ports, CVCs, and PICCs are emerging as the primary drivers of this growth.
  • In 2023, Becton Dickinson continued to maintain its dominant position as the leader in the global vascular access device and accessories market.

BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency

Retrieved on: 
Thursday, November 30, 2023
PICC, NYSE, BDX, Nursing, Patient, Central venous catheter, System, Workflow, Standard of care, Medical imaging

FRANKLIN LAKES, N.J., Nov. 30, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched a new, advanced ultrasound system designed to help improve clinician efficiency when placing peripherally inserted central catheters (PICCs), central venous catheters, IV lines and other vascular access devices.

Key Points: 
  • FRANKLIN LAKES, N.J., Nov. 30, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched a new, advanced ultrasound system designed to help improve clinician efficiency when placing peripherally inserted central catheters (PICCs), central venous catheters, IV lines and other vascular access devices.
  • The SiteRite™ 9 Ultrasound System is an all-in-one system designed with a user-friendly experience on an updated 15.6-inch touch screen with enhanced image quality that provides industry-leading catheter placement tools and technologies to support clinicians during the vascular access device insertion process.
  • Additional system capabilities include patient data look up with information capture, auto-filling capabilities and records transfer to help support clinician workflow.
  • As a global leader in vascular access solutions, BD is committed to advancing the standard of care for patients and health care providers.

Tabeeze Partners with Cincinnati Children's Hospital Medical Center to Expand its One-for-One Donation Program

Retrieved on: 
Tuesday, November 14, 2023
TIME, Sensory processing disorder, Parent, Multimedia, PICC, Senior, NICU, Life, Partnership, Development, Toy, Nursing

LOS ANGELES, Nov. 14, 2023 /PRNewswire/ -- In honor of Prematurity Awareness Month, Tabeeze, recently named TIME's Best Invention of 2023, is proud to partner with Cincinnati Children's, home to one of the largest NICUs in the US, on their one-for-one donation partnership to ensure that regardless of a family's financial situation, their baby could benefit from the comfort and convenience of Tabeeze. For every Tabeeze product sold, one gets donated to Cincinnati Children's.

Key Points: 
  • For every Tabeeze product sold, one gets donated to Cincinnati Children's.
  • "We are deeply committed to expanding our partnerships with hospitals nationwide and, eventually, worldwide," said Carrie Shaltz Haslup, Founder and CEO of Tabeeze.
  • Tabeeze was born out of founder, Carrie Shaltz Haslup , seeing her brother and sister-in-law struggle to do skin-to-skin with their baby.
  • "We're very grateful for the partnership of Tabeeze in supporting our NICU families," says Sharon Marine, Senior Vice President of Development at Cincinnati Children's.